Simvastatin has been evaluated across numerous clinical trials spanning Early Phase 1 through Phase 4, investigating conditions ranging from cardiovascular diseases and dyslipidemias to recurrent acute pancreatitis, COVID-19-mediated olfactory disorders, and type 1 diabetes. Sponsored by academic medical centers and pharmaceutical companies, these evaluations encompass various recruitment statuses, including completed, active, terminated, and not yet recruiting studies.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07779642 | NOT_YET_RECRUITING | ARDS (Acute Respiratory Distress Syndrome); Acute Hypoxic Respiratory Failure |
University of Colorado, Denver |
2026-09 | PHASE2 |
| NCT07625930 | NOT_YET_RECRUITING | Gastroesophageal Adenocarcinoma |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2027-01 | PHASE2 |
| NCT06785727 | NOT_YET_RECRUITING | Ischemic Stroke; Transient Ischemic Attack |
Prof. dr. Nathalie van der Velde |
2025-02-01 | PHASE4 |
| NCT06030622 | RECRUITING | Pancreatic Cancer Metastatic |
State University of New York - Downstate Medical Center |
2024-04-17 | PHASE1; PHASE2 |
| NCT03324425 | ACTIVE_NOT_RECRUITING | Breast Cancer Stage IV |
Baylor Breast Care Center |
2020-03-04 | PHASE2 |
| NCT04133792 | ACTIVE_NOT_RECRUITING | Primary Sclerosing Cholangitis |
Annika Bergquist |
2020-10-01 | PHASE3 |
| NCT06431919 | RECRUITING | Decompensated Cirrhosis; Cirrhotic Cardiomyopathy; Cirrhosis, Liver; Left Ventricular Diastolic Dysfunction; Acute Kidney Injury |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2025-06-10 | |
| NCT07392541 | RECRUITING | Advanced Biliary Tract Carcinoma |
Tongji Hospital |
2026-01-30 | PHASE1; PHASE2 |
| NCT07718490 | RECRUITING | Metastatic Colorectal Cancer |
The First Affiliated Hospital with Nanjing Medical University |
2025-09-01 | PHASE2 |
| NCT05771675 | RECRUITING | Recurrent Acute Pancreatitis; Chronic Pancreatitis |
Cedars-Sinai Medical Center |
2024-10-24 | EARLY_PHASE1 |
| NCT06399783 | NOT_YET_RECRUITING | Alopecia Areata |
Assiut University |
2024-10-01 | PHASE4 |
| NCT07213557 | RECRUITING | Advanced or Metastatic Gastrooesophageal Carcinoma |
National Cancer Institute, Naples |
2026-03-13 | PHASE2 |
| NCT03131726 | RECRUITING | Graves Ophthalmopathy; Thyroid Associated Ophthalmopathy; Thyroid Associated Orbitopathy |
Lund University |
2018-01-26 | PHASE3 |
| NCT03127631 | ACTIVE_NOT_RECRUITING | Prostate Cancer; Cardiovascular Disease |
McMaster University |
2015-10-21 | |
| NCT07389304 | NOT_YET_RECRUITING | Lipid Profile,Blood Pressure |
Shaheed Benazir Bhutto University Sheringal Dir Upper |
2026-03-01 | PHASE1 |
| NCT07378293 | NOT_YET_RECRUITING | Diabete Mellitus; Lipid Profile |
Shaheed Benazir Bhutto University Sheringal Dir Upper |
2026-03-01 | PHASE1 |
| NCT07003815 | NOT_YET_RECRUITING | Biliary Tract Cancer; Advanced Cancer |
Tongji Hospital |
2025-06 | PHASE2 |
| NCT07696585 | NOT_YET_RECRUITING | Alopecia Areata |
Sohag University |
2026-06-28 | |
| NCT07256561 | RECRUITING | Endodontically Retard Teeth; Periapical Radiolucency |
Hadeer Maher Mostafa Mohamed |
2025-08-10 | |
| NCT05821556 | RECRUITING | Adenocarcinoma of the Pancreas |
National Cancer Institute, Naples |
2023-06-12 | PHASE2 |
| NCT03400826 | ACTIVE_NOT_RECRUITING | Fibroid Uterus; Fibroid Tumor; Leiomyoma; Fibromyoma; Leiomyoma, Uterine |
Johns Hopkins University |
2018-08-20 | PHASE2 |
| NCT07692620 | COMPLETED | Alveolar Ridge Atrophy; Tooth Loss |
Maruwan Ali Alteer |
2025-06-02 | |
| NCT07264842 | RECRUITING | Pulpal Necrosis |
Dow University of Health Sciences |
2024-06-26 | PHASE2 |
| NCT02735707 | RECRUITING | Community-acquired Pneumonia, Influenza, COVID-19 |
UMC Utrecht |
2016-04-11 | PHASE3 |
| NCT06523465 | RECRUITING | Primary Aldosteronism; Statin; Mineralocorticoid Receptor Antagonist; Hypertension |
Third Military Medical University |
2024-09-10 | PHASE4 |
| NCT07102979 | TERMINATED | Liver Fibrosis |
Chang Gung Memorial Hospital |
2024-01-01 | |
| NCT06879171 | NOT_YET_RECRUITING | Alveolar Ridge Preservation; Horizontal Alveolar Bone Loss; Vertical Alveolar Bone Loss; Delayed Implant; Autogenous Tooth Graft |
Cairo University |
2025-06-10 | |
| NCT06948747 | COMPLETED | Healthy Participants |
AstraZeneca |
2025-05-06 | PHASE1 |
| NCT06273111 | UNKNOWN | Hemangioma Skin |
Joyce Teng |
2024-04-01 | EARLY_PHASE1 |
| NCT07194447 | COMPLETED | Dental Implants , Osseointegration , Marginal Bone Loss , Implant Stability |
Maha Zuhair |
2024-10-03 | |
| NCT03571802 | UNKNOWN | Obesity; Hyperlipidemias |
National University Hospital, Singapore |
2018-06-13 | PHASE4 |
| NCT06338241 | UNKNOWN | Bone Loss; Regenerative Inflammation |
Mario Pérez Sayáns |
2024-03-02 | PHASE4 |
| NCT05550415 | RECRUITING | Triple Negative Breast Cancer; Chemotherapy Effect; Simvastatin Adverse Reaction |
Indonesia University |
2022-08-19 | PHASE2 |
| NCT07459972 | COMPLETED | Liver Cirrhosis; Portal Hypertension Related to Cirrhosis |
Kafrelsheikh University |
2024-03-15 | PHASE4 |
| NCT04021498 | TERMINATED | Pancreatitis Relapsing |
Enrique de-Madaria |
2017-09-29 | PHASE3 |
| NCT06566794 | COMPLETED | Drug Interaction |
Helsinki University Central Hospital |
2024-08-22 | |
| NCT07031778 | RECRUITING | Dimensional Changes; Bone Density |
Universidad de Granada |
2025-01-07 | EARLY_PHASE1 |
| NCT05613400 | UNKNOWN | Diabetes Mellitus, Type 2 |
The University of Hong Kong |
2022-04-13 | PHASE4 |
| NCT01653223 | RECRUITING | Congenital Heart Disease; Heart Valve Disease |
Sun Yat-sen University |
2013-01 | |
| NCT04457089 | COMPLETED | Recurrent Ovarian Cancer; Platinum-sensitive Ovarian Cancer |
Marc Goodman |
2021-01-25 | EARLY_PHASE1 |
| NCT06379958 | UNKNOWN | Pharmacokinetics |
Modern Biosciences Ltd |
2024-04-08 | PHASE1 |
| NCT02246257 | UNKNOWN | Rheumatoid Arthritis; Cardiovascular Diseases |
MD, PhD, Annemarie Lyng Svensson |
2014-09 | |
| NCT06178640 | UNKNOWN | Healthy Volunteer |
International Bio service |
2024-08-13 | PHASE1 |
| NCT03387670 | COMPLETED | Secondary Progressive Multiple Sclerosis (SPMS) |
University College, London |
2018-03-28 | PHASE3 |
| NCT04301271 | COMPLETED | Depressive Disorder, Major; Obesity |
Charite University, Berlin, Germany |
2020-08-13 | PHASE2 |
| NCT05525013 | COMPLETED | Periapical Periodontitis |
Cairo University |
2022-10-01 | |
| NCT05677945 | UNKNOWN | Necrotic Primary Molars |
Cairo University |
2023-03 | |
| NCT05878158 | UNKNOWN | Pulp Exposure, Dental |
Ahmad Elheeny |
2023-04-01 | EARLY_PHASE1 |
| NCT05771675 | Not yet recruiting | Recurrent Acute Pancreatitis|Chronic Pancreatitis |
Cedars-Sinai Medical Center|United States Department of Defense |
2024-01 | Early Phase 1 |
| NCT05551871 | UNKNOWN | Traumatic Brain Injury |
Assiut University |
2022-10-01 | |
| NCT04514029 | ACTIVE_NOT_RECRUITING | Lymphoma |
Masonic Cancer Center, University of Minnesota |
2020-08-06 | EARLY_PHASE1 |
| NCT02946424 | UNKNOWN | Spinal Cord Injuries; Osteoporosis |
Craig Hospital |
2017-07-01 | PHASE2 |
| NCT02968810 | ACTIVE_NOT_RECRUITING | Cirrhosis; Hepatocellular Carcinoma |
National Cancer Institute (NCI) |
2017-06-21 | PHASE2 |
| NCT05542095 | WITHDRAWN | Olfactory Disorder; COVID-19 |
Washington University School of Medicine |
2023-05-01 | PHASE1 |
| NCT05542095 | Withdrawn | Olfactory Disorder|COVID-19 |
Washington University School of Medicine|Duke University |
2023-05-01 | Phase 1 |
| NCT02713945 | COMPLETED | Noonan Syndrome |
University Hospital, Toulouse |
2017-01-25 | PHASE3 |
| NCT04973800 | COMPLETED | Depression; Inflammation |
University of Oxford |
2021-07-05 | |
| NCT04992416 | COMPLETED | Autogenous Tooth Bone Graft; Immediate Implant Placement; Simvastatin |
Kafrelsheikh University |
2021-09-02 | |
| NCT03780673 | COMPLETED | Liver Cirrhoses |
Judit Pich |
2019-01-03 | PHASE2; PHASE3 |
| NCT04985201 | UNKNOWN | Small Cell Lung Cancer |
Shanghai Pulmonary Hospital, Shanghai, China |
2021-11-01 | PHASE2 |
| NCT04824898 | UNKNOWN | Intra-bony Pockets |
Ain Shams University |
2021-01-20 | PHASE1 |
| NCT06207682 | COMPLETED | Healthy Volunteers |
Amgen |
2022-06-28 | PHASE1 |
| NCT04049786 | UNKNOWN | Obesity; Bariatric Surgery; Roux-en Y Gastric Bypass |
Natalia Valadares de Moraes |
2019-06-01 | PHASE4 |
| NCT03775070 | COMPLETED | Dilated Cardiomyopathy |
National Taiwan University Hospital |
2019-01-17 | PHASE2 |
| NCT06207682 | Completed | Healthy Volunteers |
Amgen |
2022-06-28 | Phase 1 |
| NCT05582317 | COMPLETED | Pulpitis - Irreversible |
Suez Canal University |
2021-05-23 | |
| NCT05657015 | COMPLETED | Periodontitis |
Ain Shams University |
2021-09-01 | PHASE4 |
| NCT05306379 | COMPLETED | Drug-drug Interaction |
Aurinia Pharmaceuticals Inc. |
2022-01-24 | PHASE1 |
| NCT05020405 | COMPLETED | Ridge Splitting; Simvastatin; Immediate Implant |
Kafrelsheikh University |
2020-10-01 | |
| NCT06016218 | COMPLETED | Dental Caries Extending to Pulp; Dental Implant Failed |
British University In Egypt |
2021-01-05 | PHASE1; PHASE2 |
| NCT04178980 | UNKNOWN | Simvastatin Multiple Sclerosis |
Assiut University |
2020-01-01 | PHASE1 |
| NCT04698941 | UNKNOWN | Small Cell Lung Cancer |
Shanghai Pulmonary Hospital, Shanghai, China |
2021-07-25 | PHASE2 |
| NCT04507373 | TERMINATED | Muscle Cramp; Ache; Weakness, Muscle; Statin Adverse Reaction |
University of Texas Southwestern Medical Center |
2018-08-17 | PHASE4 |
| NCT05230472 | COMPLETED | VAP - Ventilator Associated Pneumonia |
Ain Shams University |
2021-01-01 | PHASE4 |
| NCT02971410 | WITHDRAWN | Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
Wake Forest University Health Sciences |
2017-04 | EARLY_PHASE1 |
| NCT03454529 | COMPLETED | Invasive Breast Carcinoma; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7 |
Michael Simon |
2018-03-09 | PHASE2 |
| NCT04652089 | COMPLETED | Depression; Inflammation |
University of Oxford |
2020-12-03 | PHASE1; PHASE2 |
| NCT02490527 | COMPLETED | Statin Intolerance |
University of California, San Diego |
2015-06 | |
| NCT04859452 | COMPLETED | Healthy Subjects |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2021-05-26 | PHASE1 |
| NCT02796378 | UNKNOWN | Cardiovascular Disease; Diabetes Mellitus |
University of Copenhagen |
2016-06 | PHASE4 |
| NCT03435744 | COMPLETED | Treatment Resistant Depression; Major Depressive Disorder |
Pakistan Institute of Living and Learning |
2019-01-01 | PHASE3 |
| NCT03134157 | UNKNOWN | Infertility |
Royan Institute |
2016-08 | PHASE3 |
| NCT04343001 | WITHDRAWN | Covid-19 |
London School of Hygiene and Tropical Medicine |
2020-10 | PHASE3 |
| NCT02871687 | COMPLETED | Healthy Subjects |
Brigham and Women's Hospital |
2016-04 | PHASE1 |
| NCT04348695 | COMPLETED | Coronavirus Infection |
Fundación de investigación HM |
2020-04-12 | PHASE2 |
| NCT03510884 | COMPLETED | Hypercholesterolaemia |
Sanofi |
2018-05-31 | PHASE3 |
| NCT02161822 | UNKNOWN | Adenocarcinoma of Rectum |
Samsung Medical Center |
2014-10-01 | PHASE2 |
| NCT03929744 | COMPLETED | Healthy |
Eli Lilly and Company |
2019-06-12 | PHASE1 |
| NCT02188121 | COMPLETED | Serious Mental Illness; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Cardiovascular Disease; Major Depressive Disorder; Psychosis NOS |
Mclean Hospital |
2015-02 | PHASE4 |
| NCT05008068 | COMPLETED | Platelet-rich Fibrin; Simvastatin |
British University In Egypt |
2019-08-12 | PHASE1 |
| NCT03086291 | UNKNOWN | Stomach Cancer |
Samsung Medical Center |
2018-01-04 | PHASE1 |
| NCT02533141 | WITHDRAWN | Healthy |
Medical University of Vienna |
2019-10 | PHASE4 |
| NCT00842920 | UNKNOWN | Mild Cognitive Impairment |
Charite University, Berlin, Germany |
2008-12 | PHASE4 |
| NCT04836078 | COMPLETED | Periodontitis |
Assiut University |
2020-02-10 | EARLY_PHASE1 |
| NCT03452891 | COMPLETED | Periodontal Diseases |
University of Nebraska |
2019-03-01 | PHASE4 |
| NCT04559841 | COMPLETED | Peri-Implantitis |
Reham Lotfy Aggour |
2017-10-06 | |
| NCT04140201 | UNKNOWN | Diabetic Retinopathy |
Alaa Hassan ElBaz |
2020-02 | PHASE4 |
| NCT04374214 | UNKNOWN | Reversible Pulpitis |
Postgraduate Institute of Dental Sciences Rohtak |
2018-12-01 | |
| NCT03543774 | UNKNOWN | Hypercholesterolemia; Chronic Kidney Diseases |
Hue University of Medicine and Pharmacy |
2018-06-15 | PHASE4 |
| NCT04149080 | UNKNOWN | Alveolar Socket Preservation; Bone Regeneration |
Universidade Federal Fluminense |
2017-11-01 | |
| NCT03653663 | UNKNOWN | Statin Adverse Reaction; Skeletal Myopathy |
Hartford Hospital |
2018-01-01 | PHASE4 |
| NCT03510715 | COMPLETED | Hypercholesterolemia |
Sanofi |
2018-08-31 | PHASE3 |
| NCT03599609 | UNKNOWN | Sickle Cell Disease; Stroke |
University of Campinas, Brazil |
2018-03-05 | PHASE1; PHASE2 |
| NCT04406883 | COMPLETED | Pain |
Islamic Azad University, Sanandaj |
2019-04-12 | PHASE2 |
| NCT01999309 | COMPLETED | Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Psychosis NOS |
Iris Sommer |
2013-10 | PHASE3 |
| NCT02787590 | COMPLETED | Parkinson Disease |
University Hospital Plymouth NHS Trust |
2016-03-08 | PHASE2 |
| NCT02743364 | COMPLETED | Acute Pancreatitis |
National Cancer Institute (NCI) |
2016-09-19 | PHASE2 |
| NCT03355027 | UNKNOWN | Atherosclerosis; Cardiovascular Diseases |
Cambridge University Hospitals NHS Foundation Trust |
2017-11-30 | |
| NCT02390843 | COMPLETED | Retinoblastoma; Clear Cell Sarcoma; Renal Cell Carcinoma; Rhabdoid Tumor; Wilms Tumor; Hepatoblastoma; Neuroblastoma; Germ Cell Tumors; Ewings Sarcoma; Non-rhabdomyosarcoma Soft Tissue Sarcoma; Osteosarcoma; Rhabdomyosarcoma |
Emory University |
2015-02 | PHASE1 |
| NCT03585751 | UNKNOWN | Tooth, Deciduous |
Cairo University |
2018-09 | |
| NCT03375580 | UNKNOWN | Nonalcoholic Fatty Liver Disease |
The First Affiliated Hospital of Guangdong Pharmaceutical University |
2017-12-31 | |
| NCT04418089 | COMPLETED | Breast Cancer; Chemotherapy Effect |
Indonesia University |
2018-01-15 | PHASE2 |
| NCT02476006 | COMPLETED | Hypercholesterolemia |
Sanofi |
2015-06-23 | PHASE3 |
| NCT03771053 | UNKNOWN | Coronary Heart Disease |
Chinese PLA General Hospital |
2018-01-01 | |
| NCT03192293 | UNKNOWN | Breast Cancer |
National University Hospital, Singapore |
2017-01-20 | PHASE2 |
| NCT03011931 | COMPLETED | Celiac Disease |
Entero Therapeutics |
2016-03 | EARLY_PHASE1 |
| NCT03247400 | COMPLETED | Non-segmental Vitiligo |
Nicolaus Copernicus University |
2016-12-01 | PHASE1; PHASE2 |
| NCT03728101 | COMPLETED | Healthy |
Korea University Guro Hospital |
2018-11-16 | PHASE1 |
| NCT04177173 | COMPLETED | Arthritis, Rheumatoid |
King Edward Medical University |
2017-09-01 | PHASE4 |
| NCT03801733 | COMPLETED | Drug Interaction Potentiation |
Akebia Therapeutics |
2018-06-17 | PHASE1 |
| NCT01106495 | COMPLETED | Atherosclerosis |
Sun Yat-sen University |
2010-05 | |
| NCT05682911 | COMPLETED | The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients |
Jinnah Sindh Medical University |
2018-01-01 | EARLY_PHASE1 |
| NCT02428374 | UNKNOWN | Myocardial Fibrosis |
Federal University of São Paulo |
2015-05 | PHASE4 |
| NCT02994485 | COMPLETED | Portal Hypertension |
Tanta University |
2016-10 | PHASE4 |
| NCT02360618 | UNKNOWN | Bladder Cancer |
London Health Sciences Centre |
2015-10 | PHASE2 |
| NCT03745300 | COMPLETED | Chronic Periodontitis Wth Diabetes Mellitus |
Government Dental College and Research Institute, Bangalore |
2017-03-03 | PHASE2; PHASE3 |
| NCT03329118 | UNKNOWN | Type 2 Diabetes |
Jiangsu HengRui Medicine Co., Ltd. |
2017-11-24 | PHASE1 |
| NCT01439555 | COMPLETED | Alzheimer's Disease |
University of Massachusetts, Worcester |
2011-11 | PHASE2 |
| NCT02285738 | COMPLETED | Solid Tumor; Cancer |
Case Comprehensive Cancer Center |
2014-12-30 | EARLY_PHASE1 |
| NCT03174041 | COMPLETED | Healthy Participants |
Genentech, Inc. |
2017-04-18 | PHASE1 |
| NCT01952288 | COMPLETED | TBI-Traumatic Brain Injury |
VA Office of Research and Development |
2013-09-16 | PHASE4 |
| NCT02766803 | UNKNOWN | PCOS, Insulin Resistance |
Poznan University of Medical Sciences |
2016-05 | PHASE4 |
| NCT03419429 | COMPLETED | Chronic Periodontitis |
Ain Shams University |
2016-01 | PHASE4 |
| NCT02026583 | COMPLETED | Colorectal Cancer |
Samsung Medical Center |
2013-12 | PHASE2 |
| NCT02096588 | TERMINATED | Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage III Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2014-05-20 | PHASE2 |
| NCT04575090 | COMPLETED | Statin-related Muscle Pain; Muscle Aches; Muscle Weakness; Muscle Cramp; Muscle Stiffness |
University of Texas Southwestern Medical Center |
2016-03-05 | |
| NCT02714569 | COMPLETED | Dyslipidemias |
Eli Lilly and Company |
2016-03 | PHASE1 |
| NCT02465645 | COMPLETED | Cirrhosis With Esophageal Varices |
Institute of Liver and Biliary Sciences, India |
2015-06-01 | |
| NCT01156545 | COMPLETED | Non-small Cell Lung Cancer |
National Cancer Center, Korea |
2010-10 | PHASE2 |
| NCT02255682 | COMPLETED | Cardiovascular Disease; Diabetes Mellitus |
University of Copenhagen |
2015-01 | PHASE4 |
| NCT01772719 | TERMINATED | Multiple Myeloma |
University of Louisville |
2012-08 | |
| NCT03400475 | COMPLETED | Peri-implant Mucositis |
Ahmed Mohamed Mahrous |
2015-04-23 | PHASE2 |
| NCT02548936 | UNKNOWN | Atherosclerosis |
Peking Union Medical College Hospital |
2015-04 | EARLY_PHASE1 |
| NCT02015988 | UNKNOWN | Acute Coronary Syndrome; Diabetes Mellitus, Type 2; Hypertriglyceridemia |
Koval' O., MD |
2014-01 | PHASE4 |
| NCT01160978 | COMPLETED | Heart Failure; Respiratory Failure; Liver Failure; Kidney Failure; Transplantation |
Helsinki University Central Hospital |
2010-06-01 | PHASE2; PHASE3 |
| NCT02360826 | COMPLETED | Drug Distribution |
Children's Mercy Hospital Kansas City |
2014-06-17 | PHASE1 |
| NCT02817243 | UNKNOWN | Type 2 Diabetes |
Jiangsu HengRui Medicine Co., Ltd. |
2016-03 | PHASE1 |
| NCT00656292 | COMPLETED | Perioperative Inflammatory Response |
Mayo Clinic |
2008-04 | PHASE4 |
| NCT02017639 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2014-01 | PHASE1 |
| NCT02675309 | COMPLETED | Healthy |
Tanabe Pharma Corporation |
2016-02 | PHASE1 |
| NCT02685462 | COMPLETED | Healthy |
Tobira Therapeutics, Inc. |
2016-01-31 | PHASE1 |
| NCT04803500 | COMPLETED | Immediate Implant Placement; Bone Regeneration; Alveolar Bone Resorption |
Ain Shams University |
2015-04-02 | PHASE2 |
| NCT04183387 | COMPLETED | Uveitis |
Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology |
2014-09 | PHASE2 |
| NCT02886299 | COMPLETED | Fenofibrate/Simvastatin Comparison |
Cairo University |
2013-10 | PHASE4 |
| NCT02547402 | COMPLETED | Acute Kidney Injury |
Complexa, Inc. |
2015-12 | PHASE1 |
| NCT02030041 | COMPLETED | Dyslipidemias |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2013-12 | PHASE3 |
| NCT02104193 | COMPLETED | Brain Metastases |
Ain Shams University |
2014-04 | PHASE2 |
| NCT02399709 | COMPLETED | Smoking Cessation |
Poitiers University Hospital |
2015-04-01 | PHASE2 |
| NCT01142336 | COMPLETED | Alzheimer's Disease |
University of Washington |
2010-06 | PHASE4 |
| NCT02542969 | COMPLETED | Healthy |
Madrigal Pharmaceuticals, Inc. |
2015-09 | PHASE1 |
| NCT02406261 | COMPLETED | Healthy |
AstraZeneca |
2015-04-30 | PHASE1 |
| NCT02431013 | UNKNOWN | Dyslipidemias; Peripheral Artery Disease |
Ajou University School of Medicine |
2015-04 | PHASE1 |
| NCT02072382 | UNKNOWN | Hypertension |
Hospital de Clinicas de Porto Alegre |
2013-05 | PHASE4 |
| NCT01771198 | TERMINATED | Rhinosinusitis |
Centre hospitalier de l'Université de Montréal (CHUM) |
2012-08 | PHASE2 |
| NCT02447601 | COMPLETED | Type 2 Diabetes Mellitus |
Jiangsu Hansoh Pharmaceutical Co., Ltd. |
2015-03-30 | PHASE1 |
| NCT01702246 | COMPLETED | Sickle Cell Disease |
UCSF Benioff Children's Hospital Oakland |
2012-02 | PHASE1; PHASE2 |
| NCT02256254 | COMPLETED | Oxidative Stress |
Rigshospitalet, Denmark |
2014-09 | PHASE2 |
| NCT01225263 | COMPLETED | Migraine |
Rami Burstein |
2010-09 | PHASE2 |
| NCT01520077 | COMPLETED | Alopecia Areata |
University of Miami |
2011-07 | PHASE1 |
| NCT00807950 | UNKNOWN | Breast Cancer |
National University Hospital, Singapore |
2008-03 | PHASE2 |
| NCT01382511 | UNKNOWN | Pachyonychia Congenita |
Tel-Aviv Sourasky Medical Center |
2011-07 | |
| NCT01420549 | COMPLETED | Hypercholesterolemia; Dyslipidemia |
Ache Laboratorios Farmaceuticos S.A. |
2013-03 | PHASE3 |
| NCT03402204 | COMPLETED | Ischemic Stroke |
Thammasat University |
2014-04-01 | PHASE3 |
| NCT01665950 | TERMINATED | Bipolar Disorder |
Massachusetts General Hospital |
2012-08 | PHASE2 |
| NCT01434745 | TERMINATED | Smith-Lemli-Opitz Syndrome |
Oregon Health and Science University |
2011-09 | |
| NCT02367937 | COMPLETED | Healthy |
Pronova BioPharma |
2014-08 | PHASE1 |
| NCT00202878 | COMPLETED | Hypercholesterolemia; Myocardial Infarction |
Organon and Co |
2005-10-17 | PHASE3 |
| NCT01944176 | COMPLETED | COPD |
Mahidol University |
2013-09 | PHASE3 |
| NCT02372656 | COMPLETED | Chronic Periodontitis |
Government Dental College and Research Institute, Bangalore |
2013-12 | PHASE2; PHASE3 |
| NCT01097785 | COMPLETED | Heart Failure |
University of Missouri-Columbia |
2009-03 | |
| NCT01561482 | WITHDRAWN | Prostate Carcinoma |
Nicholas Mitsiades |
2012-01 | PHASE2 |
| NCT01587235 | WITHDRAWN | Dyslipidemia |
Organon and Co |
2013-03 | PHASE4 |
| NCT02815722 | COMPLETED | Type 2 Diabetes |
Jiangsu HengRui Medicine Co., Ltd. |
2013-07 | PHASE1 |
| NCT01709500 | COMPLETED | Heterozygous Familial Hypercholesterolemia |
Regeneron Pharmaceuticals |
2012-12 | PHASE3 |
| NCT01321255 | COMPLETED | Myocardial Infarction |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III |
2012-01 | PHASE3 |
| NCT02134626 | COMPLETED | Portal Hypertension; Esophageal Varices; Liver Cirrhosis |
Universidade Federal do Rio de Janeiro |
2010-08 | PHASE3 |
| NCT01282385 | UNKNOWN | Liver Cirrhosis; Portal Hypertension. |
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
2011-04 | PHASE4 |
| NCT01953835 | COMPLETED | Systemic Lupus Erythematosus |
GlaxoSmithKline |
2013-10-04 | PHASE1 |
| NCT01978327 | TERMINATED | Alzheimer's Disease |
GlaxoSmithKline |
2013-11-22 | PHASE1 |
| NCT02120872 | COMPLETED | Three Wall Intrabony Defects in Chronic Periodontitis |
Government Dental College and Research Institute, Bangalore |
2013-02 | PHASE2 |
| NCT02129231 | COMPLETED | Oxidative Stress; Diabetic Polyneuropathy |
University of Guadalajara |
2012-02 | PHASE2 |
| NCT01061671 | TERMINATED | Pulmonary Disease, Chronic Obstructive |
University of Minnesota |
2010-03 | PHASE3 |
| NCT05072405 | COMPLETED | Drug Interaction |
Chinese University of Hong Kong |
2013-01-11 | PHASE4 |
| NCT01960140 | COMPLETED | Healthy Volunteers |
Eli Lilly and Company |
2013-10 | PHASE1 |
| NCT01517893 | COMPLETED | Vitiligo |
John Harris |
2012-01 | PHASE2 |
| NCT01763866 | COMPLETED | Hyperlipidemia |
Amgen |
2013-01-15 | PHASE3 |
| NCT01678820 | TERMINATED | Type 2 Diabetes Mellitus |
Merck Sharp & Dohme LLC |
2012-10-10 | PHASE3 |
| NCT01238094 | UNKNOWN | Colorectal Cancer |
Samsung Medical Center |
2010-04 | PHASE3 |
| NCT01857843 | COMPLETED | Acute Coronary Syndrome |
Yonsei University |
2009-11 | PHASE4 |
| NCT02060032 | COMPLETED | Chronic Periodontitis |
Government Dental College and Research Institute, Bangalore |
2013-02 | PHASE2; PHASE3 |
| NCT01674712 | COMPLETED | Dyslipidemia |
Abbott |
2012-06 | PHASE3 |
| NCT00995670 | COMPLETED | Hyperglycemia |
US Department of Veterans Affairs |
2010-03 | |
| NCT00994903 | COMPLETED | Intestinal Neoplasm; Perioperative Care |
University of Auckland, New Zealand |
2011-10 | PHASE3 |
| NCT01205347 | COMPLETED | Myocardial Infarction |
Brasilia Heart Study Group |
2010-10 | PHASE4 |
| NCT01095185 | COMPLETED | Cirrhosis; Hypertension, Portal; Bleeding Esophageal Varices; Portal Vein Thrombosis |
Juan A. Arnaiz |
2010-11 | PHASE3 |
| NCT00939822 | COMPLETED | Alzheimer's Disease |
University of Wisconsin, Madison |
2009-03 | PHASE2 |
| NCT01870466 | COMPLETED | Healthy |
Samsung Medical Center |
2012-06 | PHASE1 |
| NCT01923077 | UNKNOWN | Acute Myocardial Infarction |
Svendborg Hospital |
2010-04 | PHASE2 |
| NCT00731627 | COMPLETED | Subarachnoid Haemorrhage |
Cambridge University Hospitals NHS Foundation Trust |
2007-01 | PHASE3 |
| NCT00944463 | COMPLETED | Pancreatic Cancer |
Samsung Medical Center |
2008-10 | PHASE2 |
| NCT01686451 | COMPLETED | Dyslipidemias |
Wenzhou Medical University |
2012-08 | PHASE4 |
| NCT01651728 | UNKNOWN | Community-Acquired Pneumonia |
Indonesia University |
2012-07 | PHASE3 |
| NCT01654562 | TERMINATED | Choroideremia |
University of Alberta |
2012-12 | PHASE1; PHASE2 |
| NCT00879710 | COMPLETED | Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus; Hypercholesterolemia |
Medical College of Wisconsin |
2008-08 | |
| NCT01077206 | COMPLETED | Subarachnoid Hemorrhage |
Chinese University of Hong Kong |
2010-09 | PHASE2; PHASE3 |
| NCT01602029 | COMPLETED | Schizophrenia; Schizoaffective Disorder; Psychosis Not Otherwise Specified; Schizophreniform Disorder |
Pakistan Institute of Living and Learning |
2010-08 | PHASE2 |
| NCT01099085 | COMPLETED | Gastric Cancer |
Samsung Medical Center |
2009-02 | PHASE3 |
| NCT01702298 | COMPLETED | Type 2 Diabetes Mellitus |
Merck Sharp & Dohme LLC |
2012-12-07 | PHASE3 |
| NCT01179464 | COMPLETED | Bone Metastases of a Malignant Tumor |
Amsterdam UMC, location VUmc |
2010-08 | |
| NCT00572468 | COMPLETED | Cancer; Prostate Cancer |
VA Office of Research and Development |
2007-12 | |
| NCT02070133 | COMPLETED | Chronic Obstructive Pulmonary Disease |
Hospital Universitari Son Dureta |
2009-05 | PHASE3 |
| NCT00795288 | COMPLETED | Subarachnoid Hemorrhage |
Washington University School of Medicine |
2008-08 | PHASE1; PHASE2 |
| NCT01725230 | COMPLETED | Rheumatoid Arthritis |
AstraZeneca |
2012-11 | PHASE1 |
| NCT01057758 | TERMINATED | Pneumonia |
Assistance Publique Hopitaux De Marseille |
2009-09 | PHASE3 |
| NCT00321802 | COMPLETED | Atrial Fibrillation |
University of Calgary |
2006-04 | PHASE2 |
| NCT01500577 | COMPLETED | Breast Cancer |
European Institute of Oncology |
2005-04 | PHASE2 |
| NCT01666067 | COMPLETED | Hypercholesterolemia |
Gachon University Gil Medical Center |
2011-11 | PHASE4 |
| NCT01101204 | UNKNOWN | Diabetes; Dyslipidemia; Inflammation; Cytokines |
Medical University of Silesia |
2012-07 | |
| NCT00461630 | COMPLETED | Cardiovascular Disease; Peripheral Arterial Disease; Diabetes Mellitus; Coronary Heart Disease |
University of Oxford |
2007-01 | PHASE3 |
| NCT00926055 | WITHDRAWN | Atherosclerosis |
Korea University |
2011-09 | |
| NCT00120289 | TERMINATED | Cardiovascular Diseases; Heart Diseases; Cerebrovascular Accident; Coronary Disease; Atherosclerosis; Myocardial Infarction |
Axio Research. LLC |
2005-09 | PHASE3 |
| NCT01281761 | COMPLETED | Metastatic Colorectal Cancer |
Samsung Medical Center |
2010-11 | PHASE2 |
| NCT01011660 | UNKNOWN | Essential Hypertension |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2007-10 | PHASE4 |
| NCT01689623 | COMPLETED | Healthy Participants |
Janssen Research & Development, LLC |
2012-06 | PHASE1 |
| NCT01487460 | COMPLETED | Dyslipidemia; Healthy Volunteers |
Novartis Pharmaceuticals |
2011-11 | PHASE1 |
| NCT00984750 | COMPLETED | Diabetes Type 2; Hypertension |
Mario Negri Institute for Pharmacological Research |
2008-04 | PHASE3 |
| NCT01362218 | TERMINATED | Elevated LDL Cholesterol |
Ferrer Internacional S.A. |
2010-10 | PHASE2 |
| NCT01282398 | UNKNOWN | Portal Hypertension.; Liver Cirrhosis |
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
2011-04 | PHASE4 |
| NCT01342211 | COMPLETED | Hypercholesterolemia; Dyslipidemia |
Pfizer |
2011-07 | PHASE2 |
| NCT01294683 | TERMINATED | Primary Hypercholesterolemia; Dyslipidemia |
Merck Sharp & Dohme LLC |
2011-02-04 | PHASE3 |
| NCT01335997 | TERMINATED | Primary Hypercholesterolemia; Mixed Dyslipidemia |
Merck Sharp & Dohme LLC |
2011-05-01 | PHASE3 |
| NCT00575965 | TERMINATED | Waldenstrom's Macroglobulinemia |
Dana-Farber Cancer Institute |
2007-11 | PHASE2 |
| NCT01469468 | COMPLETED | Type 2 Diabetes Mellitus |
Pfizer |
2011-11 | PHASE1 |
| NCT00508027 | COMPLETED | Sickle Cell Disease |
UCSF Benioff Children's Hospital Oakland |
2007-06 | PHASE1; PHASE2 |
| NCT02304926 | COMPLETED | Dyslipidemia |
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
2009-01 | |
| NCT00647348 | COMPLETED | Secondary Progressive Multiple Sclerosis |
Imperial College London |
2008-01 | PHASE2 |
| NCT00819403 | COMPLETED | Metabolic Syndrome |
University of Maryland, Baltimore |
2009-01 | PHASE4 |
| NCT00994773 | COMPLETED | Hepatitis B |
Bader, Ted, M.D. |
2009-12 | PHASE1 |
| NCT01195428 | WITHDRAWN | Adult Respiratory Distress Syndrome; Acute Lung Injury |
University of Oklahoma |
2010-10 | |
| NCT00528580 | TERMINATED | Sepsis |
University of Chicago |
2008-02 | PHASE2 |
| NCT01383395 | COMPLETED | Healthy |
Samsung Medical Center |
2011-06 | PHASE1 |
| NCT01445860 | COMPLETED | Human Volunteers |
Pfizer |
2011-08 | PHASE1 |
| NCT01047423 | WITHDRAWN | Hypertension |
Queen's University, Belfast |
2009-08 | PHASE4 |
| NCT00605995 | TERMINATED | Schizophrenia |
New York State Psychiatric Institute |
2008-02 | |
| NCT00990834 | WITHDRAWN | Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myopathy |
Scripps Health |
2009-11 | |
| NCT01338324 | COMPLETED | Celiac Disease |
All India Institute of Medical Sciences |
2010-04 | PHASE2; PHASE3 |
| NCT01105975 | COMPLETED | Dyslipidemia |
Eli Lilly and Company |
2010-04 | PHASE2 |
| NCT00761904 | UNKNOWN | Hypertension; Hyperlipidemia |
Brigham and Women's Hospital |
2010-12 | |
| NCT01304329 | COMPLETED | Healthy |
Boehringer Ingelheim |
2011-02 | PHASE1 |
| NCT00831129 | COMPLETED | Pre-diabetes |
University of Chicago |
2006-09 | PHASE2; PHASE3 |
| NCT00862251 | COMPLETED | Cardiovascular Disorder; Diabetes Mellitus |
Organon and Co |
2009-04 | PHASE3 |
| NCT01004705 | TERMINATED | Elevated LDL Cholesterol |
Ferrer Internacional S.A. |
2009-09 | PHASE2 |
| NCT00680641 | UNKNOWN | COPD; Emphysema |
University of East Anglia |
2008-04 | PHASE4 |
| NCT00452244 | COMPLETED | Lung Cancer |
National Cancer Center, Korea |
2006-05 | PHASE2 |
| NCT02305355 | COMPLETED | Diabetes Mellitus, Type 2; Hypertriglycemia |
Kuhnil Pharmaceutical Co., Ltd. |
2009-02 | PHASE4 |
| NCT00828282 | COMPLETED | Chronic Lymphocytic Leukemia |
John Haslip |
2009-03 | PHASE1 |
| NCT00664846 | COMPLETED | Stroke |
Peking Union Medical College Hospital |
2008-04 | |
| NCT00064792 | COMPLETED | Smith-Lemli-Opitz Syndrome |
Forbes Porter, M.D. |
2003-07 | PHASE2 |
| NCT00676897 | COMPLETED | Septic Shock |
Beth Israel Deaconess Medical Center |
2008-02 | PHASE2; PHASE3 |
| NCT01290380 | TERMINATED | Solid Tumor Malignancies |
Novartis Pharmaceuticals |
2010-02 | PHASE1 |
| NCT01085149 | UNKNOWN | Hypercholesterolemia |
Hadassah Medical Organization |
2010-05 | |
| NCT00804843 | COMPLETED | Carotid Atherosclerosis |
Merck Sharp & Dohme LLC |
2009-04 | PHASE2 |
| NCT01005290 | TERMINATED | Hypertension |
Ferrer Internacional S.A. |
2009-10 | PHASE2 |
| NCT00817843 | COMPLETED | Metabolic Syndrome |
dr.Frank L.J. Visseren |
2009-04 | PHASE4 |
| NCT01147692 | COMPLETED | Diabetes Mellitus, Type 2 |
GlaxoSmithKline |
2010-05-19 | PHASE1 |
| NCT00289900 | COMPLETED | Mixed Hyperlipidemia |
Merck Sharp & Dohme LLC |
2006-01-24 | PHASE3 |
| NCT00125593 | COMPLETED | Kidney Disease, Chronic |
University of Oxford |
2003-06 | PHASE4 |
| NCT01096940 | COMPLETED | Type 2 Diabetes Mellitus |
AstraZeneca |
2010-03 | PHASE1 |
| NCT00738972 | TERMINATED | Hypertension |
Fundación Lindavista del Corazón AC |
2008-01 | PHASE3 |
| NCT01138072 | COMPLETED | Infection, Human Immunodeficiency Virus |
GlaxoSmithKline |
2010-06 | PHASE1 |
| NCT00477204 | COMPLETED | Type 1 Diabetes Mellitus; Dyslipidemia |
University of Colorado, Denver |
2007-05 | PHASE2 |
| NCT01092572 | WITHDRAWN | Cystic Fibrosis; Systemic Inflammation |
University of British Columbia |
2010-05 | PHASE1; PHASE2 |
| NCT01384058 | COMPLETED | Diabetes Mellitus Type 2; Hypercholesterolemia |
University Hospital Freiburg |
2007-11 | PHASE4 |
| NCT01103739 | COMPLETED | Chronic Pain |
Pfizer |
2010-03 | PHASE1 |
| NCT00743197 | TERMINATED | Chest Pain |
Northwestern University |
2008-05 | |
| NCT00932620 | COMPLETED | Hypercholesterolemia |
University of Ioannina |
2009-06 | PHASE4 |
| NCT00492765 | COMPLETED | Multiple Sclerosis |
Biogen |
2006-02 | PHASE4 |
| NCT00664469 | TERMINATED | Hypercholesterolemia |
Sunnybrook Health Sciences Centre |
2007-08 | PHASE3 |
| NCT01299597 | COMPLETED | Sleep Disorders |
GlaxoSmithKline |
2010-01-18 | PHASE1 |
| NCT00261326 | UNKNOWN | Optic Neuritis; Multiple Sclerosis |
Glostrup University Hospital, Copenhagen |
2006-09 | PHASE3 |
| NCT00481351 | COMPLETED | Coronary Heart Disease |
University of Sao Paulo |
2007-06 | PHASE4 |
| NCT00905905 | COMPLETED | Myocardial Infarction |
Brasilia Heart Study Group |
2009-05 | PHASE4 |
| NCT00542178 | COMPLETED | Diabetic Retinopathy |
National Heart, Lung, and Blood Institute (NHLBI) |
2003-10 | PHASE3 |
| NCT00452634 | COMPLETED | Small Cell Lung Cancer |
National Cancer Center, Korea |
2006-04 | PHASE2 |
| NCT00587678 | COMPLETED | Peripheral Artery Disease |
University of Virginia |
2006-01 | |
| NCT00384865 | TERMINATED | Hypertension, Pulmonary |
University of Pennsylvania |
2006-09 | PHASE2 |
| NCT00699023 | COMPLETED | Postprandial Lipemia; Type 2 Diabetes |
Federico II University |
2008-06 | PHASE4 |
| NCT00718796 | COMPLETED | Cardiovascular Disease |
The Canadian College of Naturopathic Medicine |
2008-04 | PHASE3 |
| NCT00704548 | UNKNOWN | Hypertension |
Hospital de Clinicas de Porto Alegre |
2008-06 | PHASE4 |
| NCT00929955 | COMPLETED | Schizophrenia; Schizoaffective Disorder; Psychosis Not Otherwise Specified; Schizophreniform Disorder |
Pakistan Institute of Living and Learning |
2009-06 | PHASE1 |
| NCT00802100 | COMPLETED | Schizophrenia |
National Institute of Mental Health (NIMH) |
2008-12 | PHASE4 |
| NCT00792337 | COMPLETED | Asthma |
Mahidol University |
2008-12 | PHASE3 |
| NCT00678743 | COMPLETED | Dyslipidemias |
Provident Clinical Research |
2007-08 | PHASE4 |
| NCT00973115 | COMPLETED | Hyperlipidemia |
Hanmi Pharmaceutical Company Limited |
2007-11 | PHASE3 |
| NCT00987558 | COMPLETED | Epilepsy |
Bial - Portela C S.A. |
2009-06 | PHASE1 |
| NCT00654628 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-08-01 | PHASE4 |
| NCT00924430 | COMPLETED | Type 2 Diabetes Mellitus |
Solvay Pharmaceuticals |
2009-06 | PHASE1 |
| NCT01061450 | COMPLETED | Diastolic Dysfunction; Hypertension |
Brasilia Heart Study Group |
2006-11 | PHASE4 |
| NCT00861731 | UNKNOWN | Hypercholesterolemia; Chronic Nephropathy |
Azienda Ospedaliero Universitaria di Sassari |
2008-11 | PHASE4 |
| NCT00404599 | UNKNOWN | Diabetes Mellitus; Hypertension |
Amsterdam UMC, location VUmc |
2007-02 | PHASE4 |
| NCT00653523 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-12-01 | PHASE3 |
| NCT00000620 | COMPLETED | Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, Type 2; Diabetes Mellitus; Coronary Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
1999-09 | PHASE3 |
| NCT00334542 | COMPLETED | Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2006-03 | PHASE2 |
| NCT00812955 | COMPLETED | Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia |
AstraZeneca |
2008-11 | PHASE3 |
| NCT00725829 | UNKNOWN | Acute Coronary Syndrome |
Jagiellonian University |
2008-06 | |
| NCT00718328 | TERMINATED | Intracerebral Hemorrhage |
Johns Hopkins University |
2008-10 | PHASE2 |
| NCT00906451 | COMPLETED | Myocardial Infarction; Inflammation; Endothelial Dysfunction |
Brasilia Heart Study Group |
2008-11 | PHASE4 |
| NCT00762164 | COMPLETED | Hypercholesterolemia |
Bronx VA Medical Center |
2007-03 | PHASE4 |
| NCT00734123 | UNKNOWN | Atherosclerosis; Cardiovascular Diseases |
Hospital Arnau de Vilanova |
2008-04 | PHASE4 |
| NCT00839683 | COMPLETED | Type 2 Diabetes Mellitus |
AstraZeneca |
2009-02 | PHASE1 |
| NCT01021579 | COMPLETED | Polycystic Ovary Syndrome |
Fasa University of Medical Sciences |
2008-01 | PHASE4 |
| NCT00503763 | WITHDRAWN | Smoldering Multiple Myeloma |
Meir Medical Center |
2007-09 | PHASE2 |
| NCT00655993 | COMPLETED | COPD; Inflammation |
VA Loma Linda Health Care System |
2008-04 | PHASE1 |
| NCT00535405 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-11 | PHASE3 |
| NCT00531882 | COMPLETED | Cystic Fibrosis |
University Hospitals Cleveland Medical Center |
2007-09 | |
| NCT00487461 | TERMINATED | Aneurysmal Subarachnoid Hemorrhage; Cerebral Vasospasm |
University of Illinois at Chicago |
2007-05 | |
| NCT00474123 | COMPLETED | Stable Angina |
University of Sao Paulo |
2006-01 | |
| NCT00208117 | TERMINATED | Depression; Coronary Artery Disease (CAD); Acute Coronary Syndrome (ACS) |
New York State Psychiatric Institute |
2005-04 | PHASE1 |
| NCT00491530 | COMPLETED | Mixed Dyslipidemia |
Abbott |
2007-06 | PHASE3 |
| NCT00354640 | COMPLETED | Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2006-06 | PHASE2 |
| NCT00180713 | COMPLETED | Pulmonary Hypertension |
Imperial College London |
2005-10 | PHASE1; PHASE2 |
| NCT00442897 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2006-09 | PHASE4 |
| NCT00443794 | COMPLETED | Cardiovascular Diseases |
St. John's Research Institute |
2007-03 | |
| NCT00349375 | COMPLETED | Hyperlipidemia |
Solvay Pharmaceuticals |
2005-11 | PHASE3 |
| NCT00525824 | COMPLETED | Hypercholesterolemia; Coronary Heart Disease; Atherosclerosis |
AstraZeneca |
2007-08 | PHASE3 |
| NCT01821027 | COMPLETED | Healthy |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2008-08 | PHASE1 |
| NCT00736606 | COMPLETED | Healthy Volunteers |
AstraZeneca |
2008-08 | PHASE1 |
| NCT00362206 | COMPLETED | Hyperlipidemia |
Solvay Pharmaceuticals |
2006-09 | PHASE3 |
| NCT00496730 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-07 | PHASE3 |
| NCT00362934 | COMPLETED | Hyperlipidemia |
Solvay Pharmaceuticals |
2006-10 | PHASE3 |
| NCT00716846 | COMPLETED | Healthy Volunteers |
Hamamatsu University |
2006-06 | |
| NCT00947323 | COMPLETED | Erectile Dysfunction; Vascular Disease Detected; C Reactive Protein |
Santa Casa de Porto Alegre |
2006-01 | PHASE3 |
| NCT00479388 | COMPLETED | Primary Hypercholesterolemia; Mixed Dyslipidemia |
Merck Sharp & Dohme LLC |
2007-07 | PHASE3 |
| NCT00769210 | COMPLETED | Heart Failure |
University of Utah |
2005-05 | EARLY_PHASE1 |
| NCT00903409 | COMPLETED | Hypertriglyceridemia |
GlaxoSmithKline |
2005-11-15 | PHASE3 |
| NCT00479882 | COMPLETED | Primary Hypercholesterolemia; Mixed Dyslipidemia |
Merck Sharp & Dohme LLC |
2007-06-15 | PHASE3 |
| NCT00462748 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-03 | PHASE3 |
| NCT00124072 | COMPLETED | Cardiovascular Disease |
University of Oxford |
1998-07 | PHASE3 |
| NCT00693576 | COMPLETED | Renal Transplantation |
Shiraz University of Medical Sciences |
2007-04 | PHASE2; PHASE3 |
| NCT00753883 | COMPLETED | Hyperlipidemia |
Merck Sharp & Dohme LLC |
2006-07 | PHASE4 |
| NCT00092677 | COMPLETED | Aortic Stenosis |
Organon and Co |
2001-01 | PHASE3 |
| NCT00669435 | UNKNOWN | Hypertension |
University of Pavia |
2008-04 | PHASE4 |
| NCT00423579 | COMPLETED | Hypercholesterolemia; Coronary Disease |
Organon and Co |
2006-07-01 | PHASE4 |
| NCT00479713 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-02-01 | PHASE3 |
| NCT00300430 | COMPLETED | Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia |
Abbott |
2006-09 | PHASE3 |
| NCT00605449 | COMPLETED | Type 2 Diabetes Mellitus |
GlaxoSmithKline |
2008-01 | PHASE1 |
| NCT00668343 | COMPLETED | Relapsing Remitting Multiple Sclerosis |
Tehran University of Medical Sciences |
2005-04 | PHASE3 |
| NCT00255242 | COMPLETED | Cystic Fibrosis |
Akron Children's Hospital |
2004-07 | PHASE1 |
| NCT00271817 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-12 | PHASE3 |
| NCT00988364 | COMPLETED | Metabolic Syndrome |
Baylor College of Medicine |
2007-03 | PHASE4 |
| NCT00465088 | COMPLETED | Hyperlipidemia; Mixed Dyslipidemia |
Abbott |
2007-04 | PHASE3 |
| NCT00560170 | COMPLETED | Atherosclerosis |
National Cheng-Kung University Hospital |
2007-09 | PHASE4 |
| NCT00359281 | COMPLETED | Healthy |
Aegerion Pharmaceuticals, Inc. |
2006-03 | PHASE2 |
| NCT00053599 | COMPLETED | Alzheimer Disease |
National Institute on Aging (NIA) |
2002-12 | PHASE3 |
| NCT00166504 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-10 | PHASE4 |
| NCT00504439 | COMPLETED | Pulmonary Disease, Chronic Obstructive |
GlaxoSmithKline |
2007-06-04 | PHASE1 |
| NCT00157924 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-11 | PHASE4 |
| NCT00943124 | COMPLETED | Dyslipidemia |
Merck Sharp & Dohme LLC |
2007-07 | PHASE1 |
| NCT00344175 | COMPLETED | Hypercholesterolemia; Dyslipidemia; Coronary Heart Disease |
Kowa Research Europe |
2006-06 | PHASE3 |
| NCT00316095 | COMPLETED | Hypertension; Dyslipidemias |
Boehringer Ingelheim |
2006-04 | PHASE3 |
| NCT00506961 | COMPLETED | Diabetes Mellitus; Dyslipidemia |
Taipei Veterans General Hospital, Taiwan |
2006-06 | PHASE4 |
| NCT00652431 | COMPLETED | Hypercholesterolemia; Hyperlipidemia |
Organon and Co |
2007-05 | PHASE1 |
| NCT00652327 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-12 | PHASE4 |
| NCT00720577 | COMPLETED | Peripheral Arterial Disease |
Medtronic Endovascular |
2005-12 | EARLY_PHASE1 |
| NCT00132717 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-01-01 | PHASE3 |
| NCT00395603 | TERMINATED | Cardiovascular Diseases; Diabetes Mellitus |
Organon and Co |
2006-09 | PHASE3 |
| NCT00129402 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-08 | PHASE3 |
| NCT00286481 | COMPLETED | Hypercholesterolemia |
Takeda |
2006-03 | PHASE3 |
| NCT00594191 | COMPLETED | Cirrhosis; Portal Hypertension |
Hospital Clinic of Barcelona |
2004-03 | PHASE2 |
| NCT00114504 | COMPLETED | Atherosclerosis |
Kurume University |
2004-09 | |
| NCT00377442 | COMPLETED | Diabetes Mellitus Type 2 |
Hoffmann-La Roche |
2006-08 | PHASE1 |
| NCT00300456 | COMPLETED | Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia |
Abbott |
2006-03 | PHASE3 |
| NCT00385658 | COMPLETED | Dyslipidemia |
Novartis |
2006-08 | PHASE4 |
| NCT00256178 | COMPLETED | Hypercholesterolemia |
Takeda |
2005-10 | PHASE3 |
| NCT00423488 | COMPLETED | Hypercholesterolemia; Diabetes Mellitus, Type 2; Coronary Disease |
Organon and Co |
2005-07-12 | PHASE3 |
| NCT00166530 | COMPLETED | Atherosclerosis |
Organon and Co |
2005-11 | PHASE4 |
| NCT02511418 | COMPLETED | Hyperlipidemia; Hypertension; Chronic Renal Failure |
Mayo Clinic |
||
| NCT00269217 | COMPLETED | Primary Hypercholesterolemia; Mixed Hyperlipidemia |
Merck Sharp & Dohme LLC |
2006-01 | PHASE3 |
| NCT00267280 | TERMINATED | Hyperlipidemia; Dyslipidemia; Hypercholesterolemia |
Pfizer |
2006-01 | PHASE3 |
| NCT00413972 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2006-04 | PHASE3 |
| NCT00309777 | COMPLETED | Hypercholesterolemia; Dyslipidemia |
Kowa Research Europe |
2005-09 | PHASE3 |
| NCT00254475 | COMPLETED | Essential Hypertension; Hypercholesterolemia |
Novartis |
2005-11 | PHASE3 |
| NCT01424891 | COMPLETED | Type 2 Diabetes; Inflammation |
Heidelberg University |
2004-04 | |
| NCT00246701 | COMPLETED | Hypertriglyceridemia |
GlaxoSmithKline |
2005-11-01 | PHASE3 |
| NCT00651014 | TERMINATED | Hypercholesterolemia; Atherosclerosis |
Organon and Co |
2004-01 | PHASE4 |
| NCT01103648 | COMPLETED | Prediabetes; Hypercholesterolemia; Inflammation; Cardiovascular Risk |
Federal University of São Paulo |
2005-06 | |
| NCT00398294 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-05-01 | PHASE4 |
| NCT00587717 | COMPLETED | Carotid Artery Disease |
Mayo Clinic |
2002-09 | |
| NCT00235963 | COMPLETED | Subarachnoid Hemorrhage; Delayed Vasospasm |
Brigham and Women's Hospital |
2002-12 | PHASE1; PHASE2 |
| NCT00397826 | COMPLETED | Hypercholesterolemia |
Cardinal Tien Hospital |
2005-01 | PHASE4 |
| NCT00171093 | COMPLETED | HYPERTENSION; HYPERCHOLESTEROLEMIA |
Novartis |
2004-09 | PHASE3 |
| NCT00651560 | COMPLETED | Hyperlipidemia |
Organon and Co |
2005-11-01 | PHASE3 |
| NCT00738296 | COMPLETED | Cardiovascular Diseases |
Hospital Universitario 12 de Octubre |
2005-04 | PHASE4 |
| NCT00110435 | COMPLETED | Type 2 Diabetes Mellitus; Hypercholesterolemia |
Organon and Co |
2005-05 | PHASE3 |
| NCT02183623 | COMPLETED | Healthy |
Boehringer Ingelheim |
2005-09 | PHASE1 |
| NCT00541697 | COMPLETED | Diabetes Mellitus, Type 2 |
Organon and Co |
2005-01-19 | PHASE3 |
| NCT00093899 | COMPLETED | Hyperlipidemia; Hypercholesterolemia; Hypertriglyceridemia |
Organon and Co |
2004-11 | PHASE3 |
| NCT00704314 | COMPLETED | Hypercholesterolemia; Diabetes; Cardiovascular Disease |
Medical University of Vienna |
2002-10 | |
| NCT01167933 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2005-01 | PHASE1 |
| NCT01167894 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2005-01 | PHASE1 |
| NCT00303277 | COMPLETED | Alzheimer's Disease; Aging |
Seattle Institute for Biomedical and Clinical Research |
2002-08 | PHASE4 |
| NCT00652717 | COMPLETED | Cardiovascular Disorder |
Organon and Co |
2005-02-01 | PHASE4 |
| NCT00650819 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2004-06-01 | PHASE3 |
| NCT00090298 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2004-04 | PHASE3 |
| NCT00688558 | COMPLETED | Dyslipidemia |
Akros Pharma Inc. |
2004-02 | PHASE2 |
| NCT00090168 | COMPLETED | Hypercholesterolemia; Atherosclerotic Disease; Coronary Disease |
Organon and Co |
2004-01-27 | PHASE3 |
| NCT00451828 | COMPLETED | Hyperlipidemia; Hypercholesterolemia; Coronary Heart Disease; Cardiovascular Disease |
UCSF Benioff Children's Hospital Oakland |
2002-03 | PHASE4 |
| NCT00650663 | COMPLETED | Hypercholesterolemia; Atherosclerosis |
Organon and Co |
2003-10-01 | PHASE4 |
| NCT00651391 | TERMINATED | Hypercholesterolemia; Atherosclerosis |
Organon and Co |
2003-10-01 | PHASE3 |
| NCT00653835 | COMPLETED | Hypercholesterolaemia; Atherosclerosis |
Organon and Co |
2003-09-01 | PHASE4 |
| NCT00651274 | COMPLETED | Atherosclerosis; Hypercholesterolemia; Coronary Heart Disease |
Organon and Co |
2003-04-01 | PHASE4 |
| NCT00652444 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2003-09 | PHASE4 |
| NCT00317993 | COMPLETED | Healthy Men |
University of Cologne |
2004-04 | PHASE4 |
| NCT00092599 | COMPLETED | Hypercholesterolemia; Coronary Disease |
Organon and Co |
2003-02 | PHASE3 |
| NCT00092612 | COMPLETED | Hypercholesterolemia; Coronary Disease |
Organon and Co |
2003-05 | PHASE3 |
| NCT00652301 | COMPLETED | Cholesterol |
Organon and Co |
2003-07 | PHASE3 |
| NCT00251576 | COMPLETED | Acute Coronary Syndrome |
Organon and Co |
1999-11-01 | PHASE3 |
| NCT00330980 | COMPLETED | Dyslipidemias |
University of California, San Diego |
2000-04 | PHASE4 |
| NCT00157911 | COMPLETED | Hypercholerolemia |
Organon and Co |
2002-12 | PHASE3 |
| NCT00092664 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2003-01 | PHASE3 |
| NCT00092651 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2002-09 | PHASE3 |
| NCT00753779 | COMPLETED | Hypercholesterolemia |
Daiichi Sankyo |
2002-11 | PHASE4 |
| NCT00385931 | COMPLETED | Hypertension; Hypercholesterolemia; Dyslipidemia |
Novartis |
2002-01 | PHASE3 |
| NCT00092157 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2002-05-01 | PHASE3 |
| NCT00551447 | COMPLETED | Coronary Disease |
Organon and Co |
2002-01 | PHASE3 |
| NCT00389896 | COMPLETED | HDL Cholesterol |
Organon and Co |
2001-07-26 | PHASE3 |
| NCT03884452 | COMPLETED | Familial Hypercholesterolemia |
Organon and Co |
2000-05-03 | PHASE3 |
| NCT02587390 | COMPLETED | Hypercholesterolemia |
NeuroBo Pharmaceuticals Inc. |
2000-05 | PHASE1 |
| NCT02187536 | COMPLETED | Healthy |
Boehringer Ingelheim |
2000-04 | PHASE1 |
| NCT00004266 | COMPLETED | Diabetic Nephropathy |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
1993-08 | PHASE3 |
| NCT00905541 | COMPLETED | Hypercholesterolemia |
University Hospital, Bonn |
1998-11 | |
| NCT00309712 | COMPLETED | Type II Diabetes Mellitus; Mixed Dyslipidemia |
Intermountain Health Care, Inc. |
2002-08 | |
| NCT00538044 | UNKNOWN | Hypertension, Pulmonary |
Capital Medical University |
2009-01 | PHASE1 |
| NCT00654446 | COMPLETED | Fredrickson Type IIa & Type IIb Dyslipidaemia |
AstraZeneca |
2002-09 | PHASE3 |
| NCT00157482 | COMPLETED | Type 2 Diabetes |
Mario Negri Institute for Pharmacological Research |
2005-01 | PHASE2 |
| NCT00654537 | COMPLETED | Hypercholesterolemia |
AstraZeneca |
2001-04 | PHASE3 |
| NCT00441844 | COMPLETED | Type 1 Diabetes |
University of California, Davis |
2002-10 | PHASE2 |
| NCT00471549 | COMPLETED | Type 2 Diabetes |
University of Aarhus |
1991-06 | PHASE4 |
| NCT00079638 | COMPLETED | Dyslipidemia; Coronary Heart Disease; Atherosclerosis; Stroke; Diabetes |
Kos Pharmaceuticals |
2004-04 | PHASE4 |
| NCT00522158 | COMPLETED | Type 2 Diabetes Mellitus; Cardiovascular Disease; LDL Cholesterol; Cognition |
Baskent University |
PHASE4 | |
| NCT00306826 | WITHDRAWN | Glucose Metabolism Disorders |
University of Leipzig |
PHASE4 | |
| NCT00259441 | COMPLETED | Kidney Failure |
Seoul National University Hospital |
2005-02 | PHASE4 |
| NCT00267267 | TERMINATED | Hyperlipidemia; Dyslipidemia |
Pfizer |
2006-01 | PHASE3 |
| NCT00080275 | COMPLETED | Hypercholesterolemia |
Kos Pharmaceuticals |
2004-03 | PHASE3 |
| NCT00365638 | COMPLETED | Polycystic Ovary Syndrome |
Poznan University of Medical Sciences |
2004-04 | |
| NCT00399867 | COMPLETED | Multiple Myeloma |
Ludwig-Maximilians - University of Munich |
2005-04 | PHASE2 |
| NCT00396513 | UNKNOWN | Polycystic Ovary Syndrome |
Poznan University of Medical Sciences |
2005-09 | |
| NCT00125060 | COMPLETED | Heart Diseases |
Johns Hopkins University |
2000-08 | |
| NCT00291863 | UNKNOWN | Renal Failure, End Stage; Peritoneal Dialysis |
Federal University of São Paulo |
2006-02 | PHASE4 |
| NCT00365001 | COMPLETED | Rheumatoid Arthritis |
Hoffmann-La Roche |
PHASE1 | |
| NCT00654173 | COMPLETED | Hypercholesterolemia |
AstraZeneca |
2002-06 | PHASE3 |
| NCT00267254 | COMPLETED | Hyperlipidemia; Dyslipidemia; Hypercholesterolemia |
Pfizer |
2006-01 | PHASE3 |
| NCT00712049 | UNKNOWN | Dyslipidemia; Atherosclerosis |
Medical University of Vienna |
2008-06 | PHASE4 |
| NCT00189085 | COMPLETED | Metabolic Syndrome |
UMC Utrecht |
2004-12 | PHASE4 |
| NCT00000941 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00185107 | COMPLETED | Hypercholesterolemia |
Daiichi Sankyo |
2005-03 | PHASE4 |
| NCT00017758 | COMPLETED | HIV Infections; HIV Seronegativity; Lipodystrophy |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00281476 | COMPLETED | Multiple Myeloma |
Vejle Hospital |
2006-02 | PHASE1; PHASE2 |
| NCT00313859 | COMPLETED | Colorectal Cancer; Metastasis |
Samsung Medical Center |
2005-09 | PHASE2 |
| NCT00141141 | COMPLETED | Hypercholesterolemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-01 | PHASE4 |
| NCT00109382 | COMPLETED | Transient Ischemic Attack; Stroke |
University of Calgary |
2003-05 | PHASE2; PHASE3 |
| NCT00466401 | COMPLETED | Hypercholesterolemia |
Ziv Hospital |
2005-02 | PHASE4 |
| NCT00285181 | COMPLETED | Healthy |
University Hospital, Montpellier |
2005-11 | |
| NCT00351286 | UNKNOWN | Peripheral Arterial Disease; Intermittent Claudication |
Angiogenix |
2006-03 | PHASE2 |
| NCT00309374 | COMPLETED | Endotoxemia |
Medical University of Vienna |
2006-03 | PHASE1 |
| NCT00000553 | COMPLETED | Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia |
University of Washington |
1994-09 | PHASE3 |
| NCT00566267 | COMPLETED | Hyperlipidemia |
Merck Sharp & Dohme LLC |
2006-04 | PHASE2; PHASE3 |
| NCT00429442 | WITHDRAWN | Relapsing Remitting Multiple Sclerosis |
Anna Tsakiri |
2008-03 | PHASE3 |
| NCT00365742 | COMPLETED | Hyperlipidemia |
Chestnut Hill Health System |
2006-04 | |
| NCT00466869 | TERMINATED | Hypercholesterolemia |
OBEcure Ltd. |
2007-05 | PHASE2 |
| NCT00159835 | COMPLETED | Cardiovascular Diseases |
Pfizer |
1999-02 | PHASE4 |
| NCT00654407 | COMPLETED | Hypercholesterolemia |
AstraZeneca |
2001-11 | PHASE3 |
| NCT00575601 | COMPLETED | Polycystic Ovary Syndrome |
Tehran University of Medical Sciences |
2007-08 | PHASE3 |
| NCT00450840 | UNKNOWN | Septic Shock |
Medical University of Vienna |
PHASE4 |
(data from https://clinicaltrials.gov, updated on 2026-08-31)
Check the
Simvastatin (MK-733)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Simvastatin (MK-733) Mechanism of Action: HMG-CoA Reductase Inhibition in Cancer Cell Research
- Simvastatin (MK-733): Selectivity & Specificity
- Simvastatin (MK-733) Working Concentration | Cell Culture | Treatment
- Simvastatin (MK-733) Solubility in DMSO
- Simvastatin (MK-733) Stock Solution
- Simvastatin (MK-733) Storage
- Simvastatin (MK-733) Stability
- Simvastatin (MK-733) Combination Database
- Simvastatin (MK-733) Molecular Weight
- Simvastatin (MK-733) SMILES
- Simvastatin (MK-733) CAS Number
- Simvastatin (MK-733) Chemical Structure (2D and 3D)
- Simvastatin (MK-733) IC50 for Cell-based and Cell-free Assays
- Simvastatin (MK-733) Cayman (10010344)? Try a better option.
- Simvastatin (MK-733) MedChemExpress (HY-17502)? Try a better option.
- Simvastatin (MK-733) Sigma (M2147)? Try a better option.
- Simvastatin (MK-733) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.